It has been shown that the absence of CCN5 drivers in BC promotes cancer cell growth and EMT, whereas up-regulation of CCN5 is associated with ER activation in normal and cancerous cells in human and mouse mammary glands [33, 34]. Here, CCN5 is linked to breast cancer.